ID   EH-GB2
AC   CVCL_6899
SY   GB2; Eastern Hepatobiliary surgery hospital-GallBladder cancer 2
DR   cancercelllines; CVCL_6899
DR   DepMap; ACH-001961
DR   Wikidata; Q54832101
RX   PubMed=22134783;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Chinese.
CC   Doubling time: ~48 hours (PubMed=22134783).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001961
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 16
ST   FGA: 22,23
ST   Penta D: 8,10
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
RX   PubMed=22134783; DOI=10.3892/or.2011.1570;
RA   Wang J.-H., Li L.-F., Yu Y., Li B., Jin H.-J., Shen D.-H., Li J.,
RA   Jiang X.-Q., Qian Q.-J.;
RT   "Establishment and characterization of a cell line, EH-GB2, derived
RT   from hepatic metastasis of gallbladder cancer.";
RL   Oncol. Rep. 27:775-782(2012).
//